Sirolimus
Drug · tier A · 8 trials (0 recruiting) · 0 publications · score 41.0
Epirubicin
Drug · tier A · 8 trials (0 recruiting) · 0 publications · score 39.5
Research map, not treatment advice. Built 2026-10-07.
2 agents linked to Bladder Cancer by at least one registered trial or two publications, ranked by the OSMF evidence score. Not treatment advice.
Research map, not treatment advice. Built 2026-10-07.